Cargando…

Large-scale molecular epidemiological analysis of AAV in a cancer patient population

Recombinant adeno-associated viruses (rAAVs) are well-established vectors for delivering therapeutic genes. However, previous reports have suggested that wild-type AAV is linked to hepatocellular carcinoma, raising concern with the safety of rAAVs. In addition, a recent long-term follow-up study in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Wanru, Xu, Guangchao, Tai, Phillip W.L., Wang, Chunmei, Luo, Li, Li, Chengjian, Hu, Xun, Xue, Jianxin, Lu, You, Zhou, Qiao, Wei, Qiang, Wen, Tianfu, Hu, Jiankun, Xiao, Yuanyuan, Yang, Li, Li, Weimin, Flotte, Terence R., Wei, Yuquan, Gao, Guangping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087635/ https://www.ncbi.nlm.nih.gov/pubmed/33782545 http://dx.doi.org/10.1038/s41388-021-01725-5

Ejemplares similares

Liver targeting with rAAV7: balancing tropism with immune profiles
por: Flotte, Terence R.
Publicado: (2021)

MicroRNA-regulated, Systemically Delivered rAAV9: A Step Closer to CNS-restricted Transgene Expression
por: Xie, Jun, et al.
Publicado: (2011)

Transcriptome Profiling of Neovascularized Corneas Reveals miR-204 as a Multi-target Biotherapy Deliverable by rAAVs
por: Lu, Yi, et al.
Publicado: (2018)

Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics
por: Su, Wenqi, et al.
Publicado: (2021)

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
por: Arjomandnejad, Motahareh, et al.
Publicado: (2023)

Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
por: Zhan, Wei, et al.
Publicado: (2021)

Long-term, efficient inhibition of microRNA function in mice using rAAV vectors
por: Xie, Jun, et al.
Publicado: (2012)

Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells
por: Arjomandnejad, Motahareh, et al.
Publicado: (2021)

Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy
por: Yang, Yeon-Suk, et al.
Publicado: (2020)

A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates
por: Wang, Dan, et al.
Publicado: (2018)

rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021)

AAV-Genome Population Sequencing of Vectors Packaging CRISPR Components Reveals Design-Influenced Heterogeneity
por: Tran, Ngoc Tam, et al.
Publicado: (2020)

Muscle-Directed Delivery of an AAV1 Vector Leads to Capsid-Specific T Cell Exhaustion in Nonhuman Primates and Humans
por: Gernoux, Gwladys, et al.
Publicado: (2020)

Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis
por: Yang, Yeon-Suk, et al.
Publicado: (2019)

Editorial: “AAV Gene Therapy: Immunology and Immunotherapeutics”
por: Martinez-Navio, José M., et al.
Publicado: (2021)

Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties
por: Hsu, Hung-Lun, et al.
Publicado: (2020)

Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction
por: Muhuri, Manish, et al.
Publicado: (2021)

Long-term Correction of Very Long-chain Acyl-CoA Dehydrogenase Deficiency in Mice Using AAV9 Gene Therapy
por: Keeler, Allison M, et al.
Publicado: (2012)

Dual-AAV split prime editor corrects the mutation and phenotype in mice with inherited retinal degeneration
por: She, Kaiqin, et al.
Publicado: (2023)

A versatile toolkit for overcoming AAV immunity
por: Li, Xuefeng, et al.
Publicado: (2022)

Size does matter: overcoming the adeno-associated virus packaging limit
por: Flotte, Terence R
Publicado: (2000)

Bridging from Intramuscular to Limb Perfusion Delivery of rAAV: Optimization in a Non-human Primate Study
por: Gruntman, Alisha M., et al.
Publicado: (2019)

Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
por: Fuchs, Sebastian P., et al.
Publicado: (2016)

Durability of transgene expression after rAAV gene therapy
por: Muhuri, Manish, et al.
Publicado: (2022)

Delivery of nVEGFi using AAV8 for the treatment of neovascular age-related macular degeneration
por: She, Kaiqin, et al.
Publicado: (2022)

Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus
por: Tang, Qiushi, et al.
Publicado: (2020)

Screened AAV variants permit efficient transduction access to supporting cells and hair cells
por: Hu, Xinde, et al.
Publicado: (2019)

Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity
por: Termini, James M., et al.
Publicado: (2020)

A Novel Xenograft Model in Zebrafish for High-Resolution Investigating Dynamics of Neovascularization in Tumors
por: Zhao, Chengjian, et al.
Publicado: (2011)

Enhanced sensitivity of neutralizing antibody detection for different AAV serotypes using HeLa cells with overexpressed AAVR
por: Zheng, Zhaoyue, et al.
Publicado: (2023)

Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
por: Martinez-Navio, José M., et al.
Publicado: (2020)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects
por: Gao, Kai, et al.
Publicado: (2014)

Rod Outer Segment Development Influences AAV-Mediated Photoreceptor Transduction After Subretinal Injection
por: Petit, Lolita, et al.
Publicado: (2017)

Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
por: Ahmadi, Elham, et al.
Publicado: (2021)

Construction of an rAAV Producer Cell Line through Synthetic Biology
por: Lee, Zion, et al.
Publicado: (2022)

A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2017)

Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model
por: Cai, Fan, et al.
Publicado: (2013)

AAV-mediated delivery of osteoblast/osteoclast-regulating miRNAs for osteoporosis therapy
por: John, Aijaz Ahmad, et al.
Publicado: (2022)

Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer
por: Zi-Bo, LI, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_3djjr8pg980odt29s7nq0hvkh7